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Abstract-Modeling is often applied to pharmacologic problems. But there are not many 
approaches to solve the associated control problems al!owing to calculate optimal ther- 
apeutics. In this paper we propose some simple methods (numerical and analytical) 
giving an explicit (or calculated) optimal therapeutic. Applications to concrete drugs 
was done. An extension to nonlinear systems is given. 
INTRODUCTION 
Modeling is not only useful to describe pharmacokinetic systems. It allows also to define 
optimal policy in the following sense. 
Taking a biological criterion (see examples below) it is possible to calculate an optimal 
policy such that the criterion be minimized (or maximized). Generally sophisticated op- 
timal control methods[l, 21 are used to solve such problems. Compartmental systems 
(linear or not) allow to use specific techniques based on Laplace transform. Classical 
literature[3] does not give very useful results in this area. We shall present original results 
for the calculus of optimal policy associated to some pharmacologic systems. More pre- 
cisely, one of the main goals of modern therapeutics is to improve both efficacy and safety 
of drugs. Therefore pharmacokinetics represent an important improvement, because 
drugs’ evolution in the body is mathematically described. If we can bind (by mathematical 
relations) the injected (or absorbed) drug to the plasmatic concentration it becomes pos- 
sible to define an optimal injection, such as to keep constant the blood concentration? of 
active product. When this approach is possible it involves practical applications for im- 
proving therapeutics. Concrete medical applications will be described in a next paper[4]. 
Let us introduce 
ential system[5, 61 
1. THE CONTROLLED SYSTEM 
the compartmental model (Fig. 1) translated by the following differ- 
XI = - (k12 + k-)x, + k2,x2 + u(t), 
.?2 = k,2x1 - k2,x2, 
x,(O) = x2(0) = 0, 
(1.1) 
t It is well known that blood concentration is directly related to the drug’s effect. 
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Fig. 1. 
where u(t) is an input (control variable), kij are exchange constants, and xi(t) is the quantity 
at time t in compartment i. 
In various compartmental models we use the following criterion and minimization 
problem: 
m (xi(t) - a)* dt, (1.2) 
where a is a particular constant value of xl(t) associated to the studied drug. 
In this paper we want to give mathematical and numerical methods solving (1.2); know- 
ing that x1 and u(t) are solutions of (1.1). 
First of all, we observe that the resolution of a control problem does not need the 
unique identification of the kij’s. In fact, suppose that we measure x?(t) corresponding 
to the initial values [xi(O) = CX, x2(O) = 01. Then it is not difficult to prove the relation 
x1(t) = k x:(t) * u(t) (1.3) 
where * designs the convolution product[7]. (1.3) is valid for every imput u(t) and x1(t) 
solution of (1.1). To show this relation (1.3), we can take the Laplace transform of (1.1). 
We obtain a convolution relation that can been easily explicited with the kij: 
x1(t) = K(t) * u(t). 
Now, taking the Laplace transform of 
x1 = - (kc + k-)x, + kxx2 + u(t), 
x2 = klzxl - kzlx2, 
x,(O) = (Y, x2(0) = 0, 
(1.4) 
corresponding to an intravenous injection at time t = 0, we obtain the same convolution 
equation between XT and CY; that is to say 
XT = K(t) * a = (Y K(t), (1.5) 
where K(t) is the same function as previously. Therefore K(t) = XT/~ is perfectly defined 
if we have an experimental data XT. 
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To solve our control problem (1.2) we do not need the numerical values of kij. We just 
need an empirical function x:(t) associated to the intravenous injection x1(O) = (Y, x*(O) 
= 0. 
The general expression of xi(t): x1 = K(t) * u(t) = (~?/a) * u(t) can be put in the 
criterion (1.2). 
In the next section, we shall see mathematical and numerical methods to solve exactly 
or approximately the control problem (1.1) and (1.2). 
2. SOLUTION USING LAPLACE TRANSFORM171 
In a previous paper[6] we solved theoretically this control problem in a particular case. 
Now we want to give the general, explicit solution of (1.1) and (1.2). Let us consider the 
differential system 
i, = - (kn + k,)xl + hx2, 
i2 = k,2x1 - k2,x2, 
(2.1) 
with initial conditions xi(O) = a, x2(O) = 0. 
Using Laplace transform leads to a relation between x1 and a. This relation is the same 
as that obtained with the differential system (1.1) taking u(t) = US, where S is the Dirac 
mass[7]. 
But we know the exact solution of the control problem associated to (2.1). The control 
function u(t) is given by [6]. 
u(t) = ak, + ak12 epkzl*. (2.2) 
We recall that this function is obtained using Laplace transform and writing a relation 
between u(t) and xl(t). In fact, for this special case we can put xl(t) = a for t z 0, and 
we deduce relation (2.2). Therefore the general solution of (1.1) and (1.2) is almost obvious 
from our previous remark. It suffices to take 
u(t) = US + ak, + ak12 eekzlr. (2.3) 
To prove (2.3) we note that u,(t) = u(t) - a6 is the solution of 
in = - (k,2 + k,)xl + kax2 + al(t), 
i2 = k,2x1 - k2,x2, 
x,(O) = a, x2(0) = 0. 
(2.4) 
The first term US in (2.3) means that we must give (at time t = 0) an instantaneous quantity 
a in compartment 1. This type of injection can only be realized approximately. 
3. NUMERICAL METHOD 
Let us consider the following general system: 
i, = - (k12 + k,)x, + k2,x.j + u(t), 
i2 = k12x1 - k2,x2, 
x*(O) = x2(0) = 0. 
(3.1) 
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(3.2) 
according to u(t). Our numerical approach is the following: 
l We use an approximation for u(t) 
u(t) # 5 cpep(r> 
p=l 
(3.3) 
where the ep are fixed and may be, for instance, polynomial, exponential, spline functions, 
etc. 
l Taking into account our previous convolution equation 
xl(t) = K(t) * u(t) = Go> - * u(t) 
a 
(3.4) 
we transform the criterion and eliminate x,(t). In fact, 
m (xl(t) - a)* dt f, min 
m n 
U 
c C,(K * e,) - a 
CI,...,C” 0 1 > 
The new optimization problem leads to a linear problem because 
J= 5 C,(K * 9,) - u)* dt 
1 
is a polynomial of degree 2 according to the unknowns C,, C2, . . . , C,. mint ,,.._, c, J is 
obtained writing necessary conditions for optimum; that is to say 
aJ aJ CYJ - = - = .., = - = 0 
ac, ac* ac, ’ (3.5) 
which is an algebraic linear system of n equations and IZ unknowns. Its resolution gives 
Cl, * . * 7 C, optimum and therefore the optimal control 
u(t) = 5 c,e,(t). 
1 
Concrete applications of this method will be given in Section 5. 
4. OPTIMAL CONTROL IN THE NONLINEAR CASE 
Many pharmakeutic problems lead to nonlinear differential systems. It is the case, for 
instance, if we want to study calcium metabolism. Idem if we are concerned with iron 
metabolism. In all these cases the general formulation is the following: 
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Find a control function u(t) such that 
i = f(x, u, t) (f given), be satisfied and minimizing (4.1) 
/ 
,,= (XI(~) - a)* dt. (4.2) 
In (4. l), x is generally a vector and f is a vector function. x1 is the first component of 
x (generally the blood compartment). We want to prove that it is possible to solve (4.1) 
and (4.2) in a quasi explicit fashion. First remark that (4.2) may be successively considered 
on intervals ( ti, ti+ ,) where it will be possible to approximate xi(t) by a linear combination 
of decreasing exponent&. Practically we can choose the (ti, ti+ 1) such that we need only 
two or three exponentials. 
We suppose furthermore that u(t) appears linearly in system (4.1). It becomes possible 
to relate x1 and u using Laplace transform as previously. We have 
Xl = Ki*U, (4.3) 
where Ki is a known function depending on the constant coefficients of the differential 
system associated to the linear combination giving xl(t). Of course Ki depends on (ti, 
ti+ 1). 
So the optimization problem becomes 
min 
u(r) 
1*(x1(t) - ~2)~ dt = min i If’+’ (x,(t) - a)’ dt 
U L,..., *a i=, Ii 
(Ki * u - a)* dt, 
where ui is the control function on (ti, ti+l). 
It remains to calculate 
(Ki * ui - a)* dt. (4.4) 
Using previous results (Section 2) we can exhibit an explicit solution for each minimization 
problem corresponding to ui. The optimal control on (tl, t2) shall be a Dirac mass added 
to an exponential combination. Then on each (ti, ti+ ,), i 2 2, we shall obtain only an 
exponential combination. These exponential combinations depends on x?(t) on each (tj, 
ti+ 1). 
Remark. As in Section 3 we can solve (4.4) using a numerical method. It suffices to 
express ui = 2 C$> Op(t> and to put this expression in (4.4). The C, are given by resolution 
of a linear algebraic system. 
Another way for obtaining the functions Ki consists to use a linearization technique[8] 
when the structure of the nonlinear model is known. For instance, let us consider the 
optimal control problem: Find u(t) minimizing 
(xl(t) - a)* dt with the constraints 
k = P(x) + u(t), 
x(0) = a. 
(4.5) 
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Where P(x) is a nonlinear vectorial function. Generally the vector u(t) has only 
component (in compartment 1) different from 0. Then we discretize the interval 
N-1 
its first 
When li = ih, for i = 1, . . . , N - 1. On each interval (ti, ti+ r) P(x) is replaced by its 
Taylor’s development of order 1 in a neighborhood of xi. More precisely, we have 
P(X) = DP(Xi)'(X - Xi) + P(Xi). (4.6) 
Where DP(xJ is the differential of P at the point xi, 
DP(Xi) = 
2 (Xi) . . . g? (xi) 
n 
. . . 
2(Xi)‘**$(Xi) 
n 
(4.7) 
Setting Ai = DP(Xi), we replace the problem (4.5) on [0, T] by a sequence of linear 
problems on (ti, ti+r): 
I 
ti+ 1 
min (xl(t) - a)’ dt, t E [ti, ti+ll, with the constraints 
u(t) fi 
i(t) = A&t) - A&i + P(Xi) + U(t), (4.8) 
X(ti) = Xi, 
where xi results of the optimization problem on [ ti _ 1, ti]. 
Systems such as (4.8) can be solved by using the explicit method developed in Section 
2 associated to some change of variables. Taking for instance x1(O) = a, and the nonlinear 
differential system[3], where 
I knx, 
We obtain 
- kn 
Ai = DP(Xi) = 
hx2 
Km Vm 
(Km + Xlo2 k21 , 
k 12 -k21 
I 
(4.9) 
(4.10) 
where xri represents xl(t) on (ti, ti+l). 
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The following formulae are easily obtained by using the Laplace transformation: 
aVm(a - Km) 
u(t) = (Km + a)2 + (kj2U - k21X2i) e-kZ’(‘-ro , 
x,(t) = a, (4.11) 
x2(t) = p + 
21 
(x2i _ 2) ,-h~f--d . 
In (4.1 l), x2i corresponds to the value of x2 calculated at ti by the previous formulae valid 
on (ti-1, ti). The formulae (4.11) have to be used on (ti, ti+ 1) giving at the end of the 
interval. 
Ui+l = u(ti+l> = 
aVm(a - Kn) 
(Km + aI2 
+ (kl2U - k21X2i) epkzlh, 
xl,i+ I = Xl(ti+l) = a7 
x2,i+ 1 = 2 + (x2j - 2) epkzlh = X2(ti+l). 
These relations will be used on (tit,, ti+2). Recall that we chose 
X2.0 = 0, x1.0 = a. 
(4.12) 
(4.13) 
5. NUMERICAL RESULTS 
Some applications were treated corresponding to concrete drugs acting on the heart 
(beta blockers). 
l First consider a linear compartmental model as in Fig. 1. The exchange parameters 
are previously identified[9, IO] from experimental data: 
k12 = 0.16, k2, = 0.13, k, = 0.07. (5.1) 
We need to realize x,(t) = a = 7. Then the numerical technique of Section 3 leads to the 
following tables where h = I/n (n to be chosen), and with 
: 
1 if t = ph, 
0 if t fZ KP - l)h, (P + l)hl, 
Mt> = 
linear between [(p - I)h, ph] and [ph, (p + l)h], 
that is to say (5.2) 
e,(t) = - t/h + (p + 1) on lph, (P + l)hl, 
%I(t) = t/h - (p - 1) on KP - lM, Ml. 
The algebraic linear system was solved using Gauss method. The C,, coefficients of u(t) 
= c CPOP(t) and the optimal control u(t) are given in the Tables l-5. 
l Then an optimal control u(t) was calculated corresponding to a two-compartments 
system (Fig. 1) associated to a beta blocker (Visken-Sandoz laboratories). 
The identified kv were the following: 
k,2 = 2.9545, kz, = 5.7214, k, = 0.3658. (5.3) 
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Table 1. 
C” 
P h = 0.5 h = 0.1 h = 0.05 h = 0.01‘ 
1 -8.501 E6 
2 2.961 E6 
3 - 6.209 E6 
4 1.022 E7 
5 -6.113 E6 
6 1.890 E6 
7 -5.349 E6 
8 - 1.738 E7 
9 1.566 E7 
10 2.559 E6 
295512 
94026.4 
80594.2 
- 161188 
- 268647 
53729.5 
- 537294 
- 805594.1 
322377 
93228.6 
155965 9302.62 
49625.1 2648.17 
42535.2 -6111.26 
- 85071.7 3530.99 
- 141786 1086.45 
-42535.3 -4074.15 
28357.3 - 14123.8 
- 283572 - 17111.5 
170143 22136.4 
49204.1 126523 
n = 10 
Table 2. 
C, in lo6 
. 
P h = 0.5 h = 0.1 h = 0.05 h = 0.01 
1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
4.04 
5.83 
11.119 
11.119 
4.081 
- 17.7 
- 77.77 
- 15.31 
-9.341 
- 10.03 
-9.34 
50.2 
- 6.02 
-73.6 
290 
9.03 
6.421 
-1.99 
4.39 
-8.13 
-9.17 
0.863 
-0.653 
40.71 
-20.2 
13.5 
- 0.926 
+ 0.726 
4.36 
- 35.41 
4.77 
3.39 
- 1.05 
2.31 
-4.29 
0.455 
-3.44 
21.50 
- 10.7 
7.14 
-25.10 
- 0.488 
4.053 
21.15 
- 18.7 
- 1.67 
1.22 
0.3334 
1.49 
-0.323 
- 1.39 
1.72 
1.96 
0.983 
1.98 
-1.39 
7.41 
6.49 
8.03 
6.42 
n = 15 
The constant a being chosen equal to 18, we want to obtain xl(r) = a for all t L 0. Then 
the method described in Section 2 leads to a Dirac mass a6 insolving x,(O) = a and a 
classical function: 
u(t) = ak, + aklz eekzlt (5.4) 
which is calculated in the Table 6. We notice that u(t) tends quickly towards a constant. 
l At last a nonlinear problem developed in [3] was numerically solved using the methods 
of Section 5. The following Tables 7-9 were obtained giving the numerical values of the 
optimal control u(t) and of the variable x2(t) associated to the second compartment. Three 
values of h (0.5, 0.3, 0.1) were tested but the numerical results are almost the same. 
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Table 3. 
Ca 
\ 
P h = 0.5 h = 0.1 h = 0.05 h = 0.01 
i 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
- 8.40 E7 
-9.78 E7 
5.28 E7 
1.34 E8 
-1.41 E8 
-1.41 E8 
4.26 E7 
2.20 E7 
- 7.77 E7 
2.14 E8 
3.16 E7 
-1.04E8 
-2.19 E8 
-3.73 ES 
1.33 E9 
7.74 E8 
6.56 E9 
-2.7 E8 
3.82 E8 
1.04 E8 
- 3.36 E8 
-7.21 E7 
4.66 E8 
- 3.50 E8 
4.27 E7 
2.42 E8 
- 8.22 E7 
-8.91 E7 
1.12 E8 
- 7.96 E8 
1.03 E8 
-6.07 E8 
1.44 E8 
9.74 E7 
-4.11 E8 
4.14 E8 
- 1.49 El0 
- 2.45 E9 
- 1.93 E9 
-7.23 ES 
-1.77 ES 
-3.80 
2.458 E8 
-1.85 E8 
2.25 El 
1.27 ES 
-4.34 E7 
-4.70 E7 
5.94 E7 
-4.20 E8 
5.44 E7 
-3.20 E8 
7.61 E7 
5.14 E7 
-2.17 E8 
2.18 E8 
-7.85 E9 
-1.29 E9 
-1.01 E9 
-3.81 E9 
4.28 E6 
- 2.89 E6 
7.75 E6 
-3.37 E6 
- 2.98 E6 
8.71 E6 
1.32 E7 
-5.17 E6 
- 8.06 E6 
-9.20 E6 
9.19 E6 
1.39 E7 
-2.28 E7 
3.55 E7 
2.33 E8 
3.77 E7 
2.33 ES 
1.89 E8 
-5.95 E7 
-401905 
n = 20 
Table 4. 
ti = ih 
i = 0,. .n 
U(G) 
\ 
n = 10 n = 15 n = 20 
0 
0.5 
1 
1.5 
2 
2.5 
3 
3.5 
4 
4.5 
5 
5.5 
6 
6.5 
7 
7.5 
8 
8.5 
9 
9.5 
10 
8.5306 E7 
8.2745 E7 
8.0186 E7 
7.7627 E7 
7.5068 E7 
7.2509 E7 
6.995 E7 
6.7391 E7 
6.4832 E7 
6.2273 E7 
5.9714 E7 
3.111 E9 
2.82269 E9 
2.52869 E9 
2.23469 E9 
1.94069 E9 
1 A4669 E9 
1.35269 E9 
1.05869 E9 
7.64686 E8 
4.70686 E8 
1.76686 E8 
1.17314 E8 
4.11314 E7 
7.05314 E6 
9.99314 ES 
1.29331 E5 
1.49667 El 1 
1.49563 El1 
1.49459 E 11 
1.49251 El1 
1.49251 El1 
1.49147 El1 
1.49043 El1 
1.48939 El1 
1.48835 El 1 
1.48731 El1 
1.48627 El 1 
1.48523 El1 
1.48419 El1 
1.48315 El1 
1.48211 El1 
1.48107 El1 
1.48003 El 1 
1.47899 El 1 
1.47795 El1 
1.47691 El1 
1.47587 E 11 
Numerical values of u(t) corresponding to h = 0.5 
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Table 5. 
ti = ih 
i = 0,. .n 
xdtd 
r . 
n = 10 n = 15 n = 20 
0 
0.5 
1 
1.5 
2 
2.5 
4 
5 
7.5 
10 
0 
1.598 
2.72384 
3.506 
4.0432 
4.404 
4.878 
4.944 
0 
2.395 
4.074 
5.2356 
6.027 
6.556 
7.225 
7.302 
7.159 
0 
2.920 
4.975 
6.404 
7.384 
8.044 
8.903 
9.029 
8.896 
8.7140 
Numerical values of xl(t) at times ti = ih for h = 
0.5 
Table 6. 
t in 
hours 0 0.1 0.2 0.3 0.5 0.8 
u(t) 59.7654 36.5953 23.5201 16.1415 9.62788 7.13134 
t in 
hours 1 1.2 1.5 1.8 2 2.5 
u(t) 6.75857 6.63987 6.59437 6.58619 6.58497 6.58443 
t in 
hours 2.8 3 4 10 20 30 
u(t) 6.58441 6.5844 6.5844 6.5844 6.5844 6.5844 
Explicit calculus of u(t) 
Table 7. 
t u(t) X2(?) 
0 
0.5 
1 
1.5 
2 
2.5 
3 
3.5 
4 
5 
6 
7 
8 
9 
10 
11 
13 
14 
2a 
21.388675908 0 
8.112227343 6.637265868 
9.228800027 9.07897526 
1.432287514 9.977235782 
0.7713874954 10.30768579 
0.5282559657 10.42925156 
0.4388128745 10.4739731 
0.4059086 10.49042524 
0.393803794 10.49647764 
0.3877124773 10.4995233 
0.3868881072 10.49993549 
0.3867765409 10.49999127 
0.386761442 10.49999882 
0.3867593986 10.49999984 . 
0.3867591221 10.49999998 
0.3867590809 10.5 
0.3867590789 10.5 
0.3867590788 10.5 
I, I, 
I, 
I, 
0.3867590788 
I, 
,, 
10.5 
Values of u(r) and x2(t) at different times 
with h = 0.5 
Table 8. 
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t u(t) x2(t) t u(t) -Q(t) 
0 21.38675908 0 0 21.38675908 0 
0.3 11.91180344 4.737477821 0.1 17.58010489 1.903327093 
X:; 6.711837529 3 8580 5731 7.337460775 8 7643 16 0.2 3 14.46348005 1 91180344 4.737477821 3 461639517
1.2 2.291836098 9.54746149 0.4 9.822667325 5.782045877 
1.5 1.432287514 9.977235782 0.5 8.112227343 6.637265868 
1.8 0.9605572502 10.21310091 0.6 6.711837529 7.337460775 
2.1 0.701666192 10.34254644 0.7 5.565295322 7.910731879 
2.4 0.5595837668 10.41358766 0.8 4.626585957 8.380086561 
2.7 0.4816072786 10.4525759 1 3.2288ooO27 9.078979526 
3 0.4388128745 10.4739731 1.5 1.432287514 9.977235782 
4.5 0.3893506847 10.4987042 2 0.7713874954 10.30768579 
6 0.3868881072 10.49993549 2.5 0.5282559657 10.42925156 
7.5 0.3867655027 10.49999679 3 0.4388128745 10.4739731 
9 0.3867593986 10.499999984 5 0.3877124773 10.49941776 
10.5 0.3867590947 10.49999999 9 0.3867593986 10.49999987 
12 0.3867590796 10.5 10.8 0.3867590875 10.5 
13.2 0.3867590788 10.5 13.2 0.3867590788 10.5 I, n I, n 
I, I, I, I, 
I, !I I, I, 
2i 0.3867590788 10.5 20 0.3867590788 10.5 
Calculus of u(t) and x2(t) with h = 0.3 Calculus of u(t) and xl(t) with h = 0.1 
6. CONCLUSIONS 
Some simple but efficient methods were presented for solving optimal therapeutics 
problems. Practical involved results were not known in the classical literature on 
pharmacokinetics[3, lo]. 
Such methods may be performed on microcalculators and their main interest is to give 
improvements for treating diseases. 
Furthermore, optimal therapeutics associated to some criterion may be discovered and 
applied on patients. 
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